The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-γ growth inhibition of human breast carcinoma cell lines

Journal of Interferon and Cytokine Research

Volumn 23, Issue 9, 2003, Pages 501-511

  Yim, John H ^a   Ro, Simon H ^b   Lowney, Jennifer K ^b   Wu, Susan J ^b   Connett, Judith ^c   Doherty, Gerard M ^c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL SURFACE RECEPTOR; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; MESSENGER RNA; STAT1 PROTEIN;

ARTICLE; BREAST CARCINOMA; CELL LINE; CELL NUCLEUS; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CARCINOMA; DNA-BINDING PROTEINS; FEMALE; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON TYPE II; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHOPROTEINS; PROTEIN TRANSPORT; RECEPTORS, INTERFERON; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0141630268     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900360708623     Document Type: Article

References (42)

1. GELLER, D.A., NGUYEN, D., SHAPIRO, R.A., NUSSLER, A., DI SILVIO, M., FREESWICK, P., WANG, S.C., TWEARDY, D.J., SIMMONS, R.L., and BILLIAR, T.R. (1993). Cytokine induction of interferon regulatory factor-1 in hepatocytes. Surgery 114, 235-242.
2. PINE, R. (1992). Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J. Virol. 66, 4470-4478.
3. COCCIA, E.M., MARZIALI, G., STELLACCI, E., PERROTTI, E., ILARI, R., ORSATTI, R., and BATTISTINI, A. (1995). Cells resistant to interferon-beta respond to interferon-gamma via the Stat1-IRF-1 pathway. Virology 211, 113-122.
4. KAMIJO, R., HARADA, H., MATSUYAMA, T., BOSLAND, M., GERECITANO, J., SHAPIRO, D, LE, J., KOH, S. I., KIMURA, T., GREEN, S.J., MAK, T.W., TANIGUCHI, T., and VILCEK, J. (1994). Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615.
5. MARTIN, E., NATHAN, C., and XIE, Q.-W. (1994). Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180, 977-984.
6. BRIKEN, V., RUFFNER, H., SCHULTZ, U., SCHWARZ, A., REIS, L.F.L., STREHLOW, I., DECKER, T., and STAEHELI, P. (1995). Interferon regulatory factor I is required for mouse Gbp gene activation by gamma interferon. Mol. Cell. Biol. 15, 975-982.
7. CHANG, C.-H., HAMMER, J., LOH, J.E., FODOR, W.L., and FLAVELL, R.A. (1992). The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1). Immunogenetics 35, 378-384.
8. LIM, S.P., and HUI, K.M. (1994). Characterization of a novel IRF-1 deficient mutant cell line. Immunogenetics 39, 168-177.
9. REIS, L.F.L., HARADA, H., WOLCHOK, J.D., TANIGUCHI, T., and VILCEK, J. (1992). Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J. 11, 185-193.
10. HOBART, M., RAMASSAR, V., GOES, N., URMSON, J., and HALLORAN, P.F. (1997). IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158, 4260-4269.
11. HOBART, M., RAMASSAR, V., GOES, N., URMSON, J., and HALLORAN, P.F. (1996). The induction of class I and II major histocompatibility complex by allogeneic stimulation is dependent on the transcription factor interferon regulatory factor 1 (IRF-1). Transplantation 62, 1895-1901.
12. YIM, J.H., WU, S.J., CASEY, M.J., NORTON, J.A., and DOHERTY, G.M. (1997). Interferon regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice. J. Immunol. 158, 1284-1292.
13. HARADA, H., WILLISON, K., SAKAKIBARA, J., MIYAMOTO, M., FUJITA, T., and TANIGUCHI, T. (1990). Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63, 303-312.
14. FUJITA, T., KIMURA, Y., MIYAMOTO, M., BARSOUMIAN, E.L., and TANIGUCHI, T. (1989). Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature 337, 270-272.
15. CHOW, W.A., FANG, J.J., and YEE, J.K. (2000). The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J. Immunol. 164, 3512-3518.
16. BLANCO, J.C., CONTURSI, C., SALKOWSKI, C.A., DEWITT, D.L., OZATO, K., and VOGEL, S.N. (2000). Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J. Exp. Med. 191, 2131-2144.
17. WATANABE, N., SAKAKIBARA, J., HOVANESSIAN, A.G., TANIGUCHI, T., and FUJITA, T. (1991). Activation of IFN-beta element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucleic Acids Res. 19, 4421-4428.
18. HARADA, H., KITAGAWA, M., TANAKA, N., YAMAMOTO, H., HARADA, K., ISHIHARA, M., and TANIGUCHI, T. (1993). Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259, 971-974.
19. TANAKA, N., ISHIHARA, M., KITAGAWA, M., HARADA, H., KIMURA, T., MATSUYAMA, T., LAMPHIER, M.S., AIZAWA, S., MAK, T.W., and TANIGUCHI, T. (1994). Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77, 829-839.
20. WILLIAM, C.L., SEVER, C.E., PALLAVICINI, M.G., HARADA, H., TANAKA, N., SLOVAK, M.L., YAMAMOTO, H., HARADA, K., MEEKER, T.C., LIST, A.F., and TANIGUCHI, T. (1993). Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259, 968-970.
21. TAMURA, G., OGASAWARA, S., NISHIZUKA, S., SAKATA, K., MAESAWA, C., SUZUKI, Y., TERASHIMA, M., SAITO, K., and SATODTE, R. (1996). Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res. 56, 612-615.
22. OGASAWARA, S., TAMURA, G., MAESAWA, C., SUZUKI, Y., ISHIDA, K., SATOH, N., UESUGI, N., SAITO, K., and SATODATE, R. (1996). Common deleted region on the long arm of chromosome 5 in esophageal carcinoma. Gastroenterology 110, 52-57.
23. LOWNEY, J.K., BOUCHER, L.D., SWANSON, P.E., and DOHERTY, G.M. (1999). Interferon regulatory factor-1 and -2 expression in human melanoma specimens. Ann. Surg. Oncol. 6, 604-608.
24. DOHERTY, G.M., BOUCHER, L., SORENSON, K., and LOWNEY, J. (2001). Interferon regulatory factor expression in human breast cancer. Ann. Surg. 233, 623-629.
25. DOHERTY, G.M., McCLUSKEY, B., TSUNG, K., and NORTON, J.A. (1995). Correlation of interferon regulatory factors 1 and 2 (IRF-1 and -2): expression and murine tumor growth in the presence of interferon-gamma. Surg. Forum 46, 544-546.
26. YIM, J.H., WU, S.J., LOWNEY, J.K., VANDER VELDE, T.L., and DOHERTY, G.M. (1999). Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon regulatory factor-2: resistance to endogenous IFN-γ. J Interferon Cytokine Res. 19, 723-729.
27. JELINEK, D.F., AAGAARD-TILLERY, K.M., ARENDT, B.K., ARORA, T., TSCHUMPER, R.C., and WESTENDORF, J.J. (1997). Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression. J. Clin. Invest. 99, 447-456.
28. FISCHER, T., AMAN, J., VAN DER KUIP, H., RUDOLF, G., PESCHEL, C., AULITZKY, W.E., and HUBER, C. (1996). Induction of interferon regulatory factors 2′-5′ oligoadenylate synthetase, p68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness. Br. J. Haematol. 92, 595-603.
29. FUJITA, T., SHIBUYA, H., HOTTA, H., YAMANISHI, K., and TANIGUCHI, T. (1987). Interferon-beta gene regulation: tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer. Cell 49, 357-367.
30. SATO, T., SELLERI, C., YOUNG, N.S., and MACIEJEWSKI, J.P. (1995). Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1. Blood 86, 3373-3380.
31. DARNELL, J.E. (1997). Stats and gene regulation. Science 277, 1630-1637.
32. SHUAI, K., STARK, G.R., KERR, I.M., and DARNELL, J.E. (1993). A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science 261, 1744-1746.
33. WONG, L.H., KRAUER, K.G., HATZINISIRIOU, I., ESTCOURT, M.J., HERSEY, P., TAM, N.D., EDMONDSON, S., DEVENISH, R.J., and RALPH, S.J. (1997). Interferon-resistant human melanoma cells are deficient in ISGF3 components, Stat1, Stat2, and p48-ISGF3γ. J. Biol. Chem. 272, 28779-28785.
34. DOHERTY, G.M., TSUNG, K., McCLUSKEY, B., and NORTON, J.A. (1996). Endogenous interferon-gamma acts directly on tumor cells in vivo to suppress growth. J. Surg. Res. 64, 68-74.
35. DOHERTY, G.M., ALEXANDER, H.R., MERINO, M.J., VENZON, D.J., and NORTON, J.A. (1996). Role of endogenous interferon gamma in routine tumor growth and tumor necrosis factor alpha antitumor efficacy. Ann. Surg. Oncol. 3, 198-203.
36. DOHERTY, G.M., LANGE, J.R., LANGSTEIN, H.N., ALEXANDER, H.R., BIRESH, C.M., and NORTON, J.A. (1992). Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J. Immunol. 149, 1666-1670.
37. NASTALA, C.L., EDINGTON, H.D., McKINNEY, T.G., TAHARA, H., NALESNIK, M.A., BRUNDA, M.J., GATELY, M.K., WOLF, S.F., SCHREIBER, R.D., STORKUS, W.J., and LOTZE, M.T. (1994). Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol. 153, 1697-1706.
38. HARADA, H., FUJITA, T., MIYAMOTO, M., KIMURA, Y., MURAYAMA, M., FURIA, A., MIYATA, T., and TANIGUCHI, T. (1989). Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58, 729-739.
39. CHA, Y. and DEISSEROTH, A.B. (1994). Human interferon regulartory factor 2 gene. J. Biol. Chem. 269, 5279-5287.
40. KIRCHHOFF, S., KOROMILAS, A.E., SCHAPER, F., GRASHOFF, M., SONENBERG, N., and HAUSER, H. (1995). IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11, 439-445.
41. TANAKA, N., KAWAKAMI, T., and TANIGUCHI, T. (1993). Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13, 4531-4538.
42. SOK-PIN TAN, R., TANIGUCHI, T., and HARADA, H. (1996). Identification of the lysyl oxidase gene as a target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Res. 56, 2417-2421.